Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Reelin controls the positioning of brainstem serotonergic raphe neurons.

Shehabeldin R, Lutz D, Karsak M, Frotscher M, Krieglstein K, Sharaf A.

PLoS One. 2018 Jul 12;13(7):e0200268. doi: 10.1371/journal.pone.0200268. eCollection 2018.

2.

Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs.

Dumitru CA, Sandalcioglu IE, Karsak M.

Front Mol Neurosci. 2018 May 16;11:159. doi: 10.3389/fnmol.2018.00159. eCollection 2018. Review.

3.

Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.

Pasquarelli N, Engelskirchen M, Hanselmann J, Endres S, Porazik C, Bayer H, Buck E, Karsak M, Weydt P, Ferger B, Witting A.

Neuropharmacology. 2017 Sep 15;124:157-169. doi: 10.1016/j.neuropharm.2017.03.037. Epub 2017 Mar 31.

PMID:
28373073
4.

Cannabinoid receptor 2 expression modulates Gβ(1)γ(2) protein interaction with the activator of G protein signalling 2/dynein light chain protein Tctex-1.

Nagler M, Palkowitsch L, Rading S, Moepps B, Karsak M.

Biochem Pharmacol. 2016 Jan 1;99:60-72. doi: 10.1016/j.bcp.2015.09.017. Epub 2015 Sep 26.

PMID:
26410677
5.

Protective role of palmitoylethanolamide in contact allergic dermatitis.

Petrosino S, Cristino L, Karsak M, Gaffal E, Ueda N, Tüting T, Bisogno T, De Filippis D, D'Amico A, Saturnino C, Orlando P, Zimmer A, Iuvone T, Di Marzo V.

Allergy. 2010 Jun 1;65(6):698-711. doi: 10.1111/j.1398-9995.2009.02254.x. Epub 2009 Nov 11.

PMID:
19909294
6.

The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample.

Karsak M, Malkin I, Toliat MR, Kubisch C, Nürnberg P, Zimmer A, Livshits G.

Hum Genet. 2009 Nov;126(5):629-36. doi: 10.1007/s00439-009-0708-8. Epub 2009 Jun 30.

PMID:
19565271
7.

Beta-caryophyllene is a dietary cannabinoid.

Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A.

Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9099-104. doi: 10.1073/pnas.0803601105. Epub 2008 Jun 23.

8.

CB2 receptors as new therapeutic targets for liver diseases.

Lotersztajn S, Teixeira-Clerc F, Julien B, Deveaux V, Ichigotani Y, Manin S, Tran-Van-Nhieu J, Karsak M, Zimmer A, Mallat A.

Br J Pharmacol. 2008 Jan;153(2):286-9. Epub 2007 Oct 22. Review.

9.

The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling.

Tam J, Trembovler V, Di Marzo V, Petrosino S, Leo G, Alexandrovich A, Regev E, Casap N, Shteyer A, Ledent C, Karsak M, Zimmer A, Mechoulam R, Yirmiya R, Shohami E, Bab I.

FASEB J. 2008 Jan;22(1):285-94. Epub 2007 Aug 17.

PMID:
17704191
10.

Attenuation of allergic contact dermatitis through the endocannabinoid system.

Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tüting T, Zimmer A.

Science. 2007 Jun 8;316(5830):1494-7.

11.

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Ramirez A, Heimbach A, Gründemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C.

Nat Genet. 2006 Oct;38(10):1184-91. Epub 2006 Sep 10.

PMID:
16964263
12.

Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice.

Valverde O, Karsak M, Zimmer A.

Handb Exp Pharmacol. 2005;(168):117-45. Review.

PMID:
16596773
13.

Peripheral cannabinoid receptor, CB2, regulates bone mass.

Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I.

Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):696-701. Epub 2006 Jan 9.

14.

Cannabinoid receptor type 2 gene is associated with human osteoporosis.

Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U, Essig J, Erxlebe E, Bab I, Kubisch C, de Vernejoul MC, Zimmer A.

Hum Mol Genet. 2005 Nov 15;14(22):3389-96. Epub 2005 Oct 4.

PMID:
16204352
15.

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, Karsak M, Zimmer A, Frossard JL, Mach F.

Nature. 2005 Apr 7;434(7034):782-6. Erratum in: Nature. 2005 May 26;435(7041):528. Karsak, Meliha [added].

16.

Antifibrogenic role of the cannabinoid receptor CB2 in the liver.

Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S.

Gastroenterology. 2005 Mar;128(3):742-55.

PMID:
15765409
17.

NB-3/Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes.

Cui XY, Hu QD, Tekaya M, Shimoda Y, Ang BT, Nie DY, Sun L, Hu WP, Karsak M, Duka T, Takeda Y, Ou LY, Dawe GS, Yu FG, Ahmed S, Jin LH, Schachner M, Watanabe K, Arsenijevic Y, Xiao ZC.

J Biol Chem. 2004 Jun 11;279(24):25858-65. Epub 2004 Apr 12.

18.

F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation.

Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, Duka T, Takeda Y, Chia W, Sankar N, Ng YK, Ling EA, Maciag T, Small D, Trifonova R, Kopan R, Okano H, Nakafuku M, Chiba S, Hirai H, Aster JC, Schachner M, Pallen CJ, Watanabe K, Xiao ZC.

Cell. 2003 Oct 17;115(2):163-75.

Supplemental Content

Loading ...
Support Center